東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Structure-based drug design: What t...

Pressman, Julie Schames.

Linked to FindBook

Google Book

Amazon

博客來

Structure-based drug design: What to do when you don't have a structure.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Structure-based drug design: What to do when you don't have a structure./
Author:	Pressman, Julie Schames.
Description:	77 p.
Notes:	Source: Dissertation Abstracts International, Volume: 66-04, Section: B, page: 1998.
Contained By:	Dissertation Abstracts International66-04B.
Subject:	Health Sciences, Pharmacology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3170248
ISBN:	0542069490

Structure-based drug design: What to do when you don't have a structure.
Pressman, Julie Schames.

Structure-based drug design: What to do when you don't have a structure. - 77 p.

Source: Dissertation Abstracts International, Volume: 66-04, Section: B, page: 1998.

Thesis (Ph.D.)--University of California, San Diego, 2005.

By name, structure-based drug design relies on having the structure of the protein and ligand of interest as a starting point. Because structural determination is difficult, there are many proteins of clinical interest whose structures have not yet been determined. In some cases, protein structures may be ambiguously known. Three cases are set forth, each with protein and ligand structures unresolved, to varying degrees. New approaches are devised to allow for a better understanding of the likely structures of the protein-ligand complexes.

ISBN: 0542069490Subjects--Topical Terms:

1017717
Health Sciences, Pharmacology.

Structure-based drug design: What to do when you don't have a structure.
LDR:02608nmm 2200301 4500 001 1813825
005 20060503081253.5
008 130610s2005 eng d
020 $a 0542069490
035 $a (UnM)AAI3170248
035 $a AAI3170248
040 $a UnM $c UnM
100 1 $a Pressman, Julie Schames. $3 1903315
245 1 0 $a Structure-based drug design: What to do when you don't have a structure.
300 $a 77 p.
500 $a Source: Dissertation Abstracts International, Volume: 66-04, Section: B, page: 1998.
500 $a Chair: J. Andrew McCammon.
502 $a Thesis (Ph.D.)--University of California, San Diego, 2005.
520 $a By name, structure-based drug design relies on having the structure of the protein and ligand of interest as a starting point. Because structural determination is difficult, there are many proteins of clinical interest whose structures have not yet been determined. In some cases, protein structures may be ambiguously known. Three cases are set forth, each with protein and ligand structures unresolved, to varying degrees. New approaches are devised to allow for a better understanding of the likely structures of the protein-ligand complexes.
520 $a The Relaxed-Complex method is introduced, and is used to elucidate the binding mode of the 5CITEP inhibitor for HIV integrase. Further work identifies a novel trench near the active site of integrase that should be considered for future anti-HIV integrase drug design.
520 $a The Exhaustive Restrained Minimization Algorithm (ERMA) was devised to discover the likely binding mode of a known MMP-3 inhibitor for the metalloenzyme, a complex whose structure had been unknown previously. The computationally determined complex conformation of MMP-3 with its inhibitor was used as a starting point for de novo drug design for MMP-3 inhibitors, with mildly successful initial results.
520 $a I have shown new ways of accounting for protein flexibility with molecular docking, and have introduce two new methods, the Relaxed-Complex and Exhaustive Restrained Minimization Algorithm, that allow for structure-based drug design in cases where the structure of the protein-ligand complex is not confidently known. These approaches should be used for further work, along with increased ways of accounting for protein flexibility in structure-based drug design.
590 $a School code: 0033.
650 4 $a Health Sciences, Pharmacology. $3 1017717
690 $a 0419
710 2 0 $a University of California, San Diego. $3 1018093
773 0 $t Dissertation Abstracts International $g 66-04B.
790 1 0 $a McCammon, J. Andrew, $e advisor
790 $a 0033
791 $a Ph.D.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3170248